|
Re: Trial results
|
3
|
Mannkind
|
Jun 07, 2013 10:42AM
|
|
Valuations
|
3
|
Mannkind
|
Nov 05, 2012 06:57PM
|
|
Re: Updated Share Price Model
|
3
|
Mannkind
|
Jan 12, 2013 08:41PM
|
|
Re: Short interest????
|
3
|
Mannkind
|
May 26, 2013 05:36PM
|
|
Re: ProBoards: not as pro
|
3
|
Mannkind
|
Aug 23, 2013 12:33PM
|
|
Re: Confused: Out of Money Call preminus are down
|
3
|
Mannkind
|
Aug 14, 2013 02:32PM
|
|
Renaissance Technologies
|
3
|
Mannkind
|
Aug 13, 2013 02:11PM
|
|
Hypoglycemia on the Rise
|
3
|
Mannkind
|
Jul 03, 2013 02:45PM
|
|
Re: Updated Share Price Model
|
4
|
Mannkind
|
Jan 28, 2013 11:52AM
|
|
Re: Valuations
|
4
|
Mannkind
|
Nov 09, 2012 04:08PM
|
|
High Stress Can Make Insulin Cells Regress
|
4
|
Mannkind
|
Oct 02, 2012 08:53PM
|
|
Re: 10-Q
|
4
|
Mannkind
|
Nov 10, 2012 12:55PM
|
|
Re: Mannkind's Afrezza May Be Half As Effective As Current Injectable Insulins
|
5
|
Mannkind
|
Aug 15, 2013 06:35PM
|
|
Re: Updated Share Price Model
|
5
|
Mannkind
|
Jan 16, 2013 08:30PM
|
|
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 DM
|
5
|
Mannkind
|
Jun 17, 2013 08:10AM
|
|
Re: New from Novo..
|
5
|
Mannkind
|
Jun 24, 2013 05:21PM
|
|
Re: Call options
|
5
|
Mannkind
|
May 17, 2013 12:36PM
|
|
Re: We need to move forward and figure the best way
|
5
|
Mannkind
|
Aug 16, 2013 09:17AM
|
|
Re: CC Notes / Financing and Partnership Discussion
|
5
|
Mannkind
|
Feb 12, 2013 11:54PM
|
|
Re: MannKind announces $160M debt financing
|
5
|
Mannkind
|
Jul 01, 2013 10:02AM
|
